Background: Victorian Institute of Sports Assessment (VISA-A) is a patient-reported outcome for assessing symptoms severity associated with Achilles tendinopathy (AT). It is a valid and reliable tool that has been used widely for measuring and monitoring treatment outcomes for AT. This clinical measurement study aims to develop a Chinese version of the VISA-A questionnaire. The study objective is to adapt the VISA-A questionnaire cross-culturally and assess its psychometric property for Chinese-speaking individuals. Methods: VISA-A was translated and adapted cross-culturally according to international guidelines for self-reported questionnaires. During the establishment of Chinese VISA-A, there are 5 stages involved in the creation process, including translation, synthesis, reverse translation, review, and pretesting, which are performed by professionals in various fields, including orthopaedic surgeons, physiotherapists, and professional translators. Results: A total of 60 participants were recruited to complete the Chinese VISA-A and 36-Item Short Form Health Survey (SF-36) questionnaires. The overall test-retest reliability was 0.98 (intraclass correlation coefficient = 0.97-0.99). The correlation between Chinese VISA-A and physical function subscale ( r = 0.70) was strong and statistically significant. There were moderate correlations between Chinese VISA-A, limitations to role of physical function subscale ( r = 0.30), and bodily pain subscale ( r = 0.42), which were also statistically significant. There were statistically significant differences in Chinese VISA-A scores between healthy control and pathologic group ( P < .001), at-risk group, and pathologic group ( P < .001) respectively. Conclusion: Chinese VISA-A demonstrated good reliability and validity for measuring symptom severity in patients with AT. Chinese VISA-A can be recommended as a self-reported measure for monitoring symptoms severity and treatment progress of patients with Achilles tendinopathy. Level of Evidence: Level II, cohort study.
To compare peroneal muscle quality between individuals with chronic ankle instability (CAI) and healthy controls, and to examine their relationship with ankle stability. Case-control study. Sports Medicine research laboratory. Sixty-five participants (35 with unilateral CAI, 30 healthy controls) were assessed. Peroneal muscle size, echogenicity, and passive stiffness were measured using ultrasound imaging and eversion strength was assessed with a hand-held dynamometer. Ankle stability was evaluated using the Y Balance Test (YBT), lateral step-down, and single-leg stance tests. Compared to controls, individuals with CAI showed significantly lower eversion strength, higher muscle echogenicity, and increased passive stiffness. In the CAI group, greater stiffness and reduced strength were associated with higher centre of pressure displacement during single-leg stance. Higher eversion strength was associated with increased YBT scores across all participants. Echogenicity was not directly associated with stability functions. Deficits in peroneal muscle quality, involving echogenicity, strength and stiffness, are demonstrated in the CAI population. These factors are associated with impaired instability among CAI individuals. Interventions targeting peroneal muscle quality may improve balance and reduce the risk of recurrent ankle injuries in this population.
Topical analgesics are increasingly recognised as an essential part of treatment for painful musculoskeletal conditions, valued for their localised effectiveness and safer profile compared to systemic options. Recent evidence suggests that the effects of topical analgesics go beyond simply alleviating pain from sports injuries; they also enhance sports performance immediately after application. We conducted a local survey of 141 adults engaging in exercise to gain insight into the use patterns and perceptions of topical analgesics; 102 reported using over-the-counter topical analgesics. Fisher–Freeman–Halton analyses confirmed that usage habits were similar between younger (21–30 years) and older (≥31 years) age groups, as well as between those exercising more frequently (≥3 times per week) and less frequently (once or twice per week). Participants typically employed topical analgesics to alleviate muscle aches, pain, or soreness (n = 92, 90.2%), relieve joint pain or discomfort (n = 57, 55.9%), and/or reduce muscle stiffness (n = 39, 38.2%). Most applied them at home as needed (n = 71, 69.6%), with some participants using them after exercise (n = 60, 58.8%). Regarding the frequency of topical analgesic use, most participants used analgesics fewer than five times a year (n = 54, 52.9%). Over half of the participants viewed topical analgesics as effective or very effective. To conclude, our survey revealed that adults engaging in exercise commonly used topical analgesics to relieve musculoskeletal pain or discomfort as needed.